US court dismisses infringement, allows trade secret theft claims against Nevro

A US district court has partially granted medical devices maker Nevro’s motion to dismiss patent infringement claims against the company by a competitor, Boston Scientific.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Nevro escalates patent dispute with Boston Scientific

25 February 2021 Medical device maker Nevro has hit competitor Boston Scientific with a lawsuit for allegedly infringing patents that cover a spinal cord stimulation technology.

Americas

Boston Scientific and Nevro conclude patent dispute

16 December 2020 Medical device company Nevro has agreed to drop a patent infringement suit which accused Boston Scientific of infringing patents related to spinal cord stimulation (SCS) therapy.

Americas

FTC demands Boston Scientific divest business amid $4.2bn deal

8 August 2019 The US Federal Trade Commission is requiring medical device maker Boston Scientific to divest business, as part of a settlement resolving antitrust charges related to its acquisition of UK-based healthcare company BTG.

More features

The Quintara decision: Defining trade secrets in federal cases

To disclose or not: Pharma patents face new AI reality

Trade secrets go global: How brand owners face a high-stakes battlefront

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation (Part I): Follow the money

Buchalter brings in new partner to head up medtech

US court dismisses infringement, allows trade secret theft claims against Nevro

More on this story

Editor's picks

Editor's picks

More features